James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, Compérat E, Eeles R, Fatiregun O, Grist E, Halabi S, Haran Á, Herchenhorn D, Hofman MS, Jalloh M, Loeb S, MacNair A, Mahal B, Mendes L, Moghul M, Moore C, Morgans A, Morris M, Murphy D, Murthy V, Nguyen PL, Padhani A, Parker C, Rush H, Sculpher M, Soule H, Sydes MR, Tilki D, Tunariu N, Villanti P, Xie LP.
“The Lancet Commission on prostate cancer: planning for the surge in cases.”
Lancet. 2024 Apr 27;403(10437):1683-1722.
Link: https://pubmed.ncbi.nlm.nih.gov/38583453/
In this Lancet Commission, we report future projections for prostate cancer incidence and mortality, as well as detailed strategies for managing the expected surge in cases in low and middle income countries and high-income countries. Urgent action is needed to expand access and reduce disparities in care to avoid an increasing number of prostate cancer deaths globally. .